According to Aeterna Zentaris's latest financial reports and stock price the company's current Operating Margin is -161.15%. At the end of 2021 the company had an Operating Margin of -161.16%.
Year | Operating Margin | Change |
---|---|---|
2021 | -161.16% | 24.61% |
2020 | -129.33% | -88.96% |
2019 | -1,171.05% | -3365.8% |
2018 | 35.86% | -101.63% |
2017 | -2,196.64% | -19.82% |
2016 | -2,739.74% | -70.27% |
2015 | -9,216.15% | -94.06% |
2014 | -155,236.36% | 35090.33% |
2013 | -441.13% | 627.55% |
2012 | -60.63% | -15.8% |
2011 | -72.01% | -14.08% |
2010 | -83.81% | 114.36% |
2009 | -39.10% | -74.35% |
2008 | -152.40% | 88.58% |
2007 | -80.82% | 53.24% |
2006 | -52.74% | -2287.19% |
2005 | 2.41% | -40.43% |
2004 | 4.05% | -136.32% |
2003 | -11.14% | -38% |
2002 | -17.97% | -46.99% |
2001 | -33.91% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() Novartis NVS | 17.27% | -110.72% | ๐จ๐ญ Switzerland |
![]() Sanofi SNY | 18.21% | -111.30% | ๐ซ๐ท France |
![]() Bristol-Myers Squibb BMY | 19.24% | -111.94% | ๐บ๐ธ USA |
![]() Spectrum Pharmaceuticals
SPPI | -109.76% | -31.89% | ๐บ๐ธ USA |
![]() Halozyme Therapeutics HALO | 37.47% | -123.25% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.